Patent Publication Number: US-2013245575-A1

Title: Body product and method of delivery

Description:
CROSS REFERENCE TO RELATED APPLICATIONS 
     This application claims priority to currently pending U.S. Provisional Application Ser. No. 61/685,272; filed on Mar. 14, 2012; titled DELIVERY METHOD OF TOPICAL AND EXTERNAL BODY PRODUCTS. 
    
    
     FIELD OF THE INVENTION 
     This invention relates to a delivery system for the application of topical and external body products and, more specifically a topical and external composition and method for administering topical and external topical and external body products for prevention and treatment of anal/vaginal ailments, such as diaper rash and hemorrhoids, in a fast no-mess manner while reducing or preventing the risk of cross-contamination. 
     STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT 
     None 
     REFERENCE TO A MICROFICHE APPENDIX 
     None 
     BACKGROUND OF THE INVENTION 
     Currently, topical and external body products on the market that cater to prevention and treatment of anal/vaginal ailments or for children, adults, and elderly persons are generally made in forms of creams, salves, and ointments. It should be noted that topical and external body products, as defined hereinafter, are a category of body products that are specifically design to be use only on the exterior surfaces of the body in treating ailments such as various type of rash and hemorrhoids especially in the regions of the body human body that may be more susceptible to cross-contamination anal area and vaginal area. These products have inherent viscous properties and therefore are messy in application and involve necessary clean-up by the person applying the product after each use. The topical and external products that are available to date typically involve an application method that is inconvenient and extremely unhygienic to all people involved. In instances where a person comes in contact with any part of the anal/vaginal area, the risk of cross-contamination is very high. 
     There thus is a need for a composition and method for administering topical and external topical and external body products for prevention and treatment of anal/vaginal ailments in a fast no-mess manner while reducing or preventing the risk of cross-contamination between multiple users and between person(s) applying the product. 
     BRIEF SUMMARY OF THE INVENTION 
     The present invention comprises a composition and a sanitary method for administering topical and external topical and external body products for prevention and treatment of anal/vaginal ailments, the composition comprising a mixture of a melting agent, a healing agent, a hardening agent, a moisture barrier agent, and a carrier agent, with the mixture sandwiched between a first and second protective layer and in solid state and undergoing a phase change to a lubricating state when applied to a human body. 
     The sanitary method of administering topical and external topical and external body products for the prevention and treatment of anal/vaginal ailments comprising the steps of selecting a single dose of anal/vaginal treatment composition, peeling a first protective layer from the single dose of anal/vaginal treatment composition to expose a body-treating surface while maintaining a second protective layer on the single dose of anal/vaginal treatment composition, applying the body-treating surface of the single dose of anal/vaginal treatment composition to the receiver&#39;s body while preventing the user&#39;s fingers from coming into contact with the receiver&#39;s skin, and maintaining the single dose of anal/vaginal treatment composition to the receiver&#39;s body to trigger a phase change of the single dose of anal/vaginal treatment composition from a solid state to a liquid state. 
    
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
         FIG. 1  shows a top view of an embodiment of an anal/vaginal treatment composition of the present invention in individually wrapped single dose form; 
         FIG. 2  shows a side view of the individually wrapped single dose anal/vaginal treatment composition of  FIG. 1 ; and 
         FIG. 3  shows a side view of an embodiment of an anal/vaginal treatment composition in roll form. 
     
    
    
     DESCRIPTION OF THE PREFERRED EMBODIMENT 
     The present invention comprises a composition for administering topical and external body products for the prevention and treatment of anal/vaginal ailments. The composition generally comprises a mixture of a melting agent, a healing agent, a hardening agent, a moisture barrier agent, and a carrier agent wherein the composition is in solid form and changes to liquid form when applied to the human body. Although the various agents for the composition preferably comprises organic ingredients, synthetic ingredients, or a mixture of both may be used to create a formula for the composition. 
     Examples of some of the possible but non-limiting organic ingredients that may be used for the agents of the above composition includes the melting agent selected from the group comprising of Coconut Oil, Cocoa Butter, and Shea Butter. The healing agent of the composition selected from the group comprising of Calendula, Shea Butter, Sunflower oil, Aloe Vera, Lavender Oil, and Vitamin E. The hardening agent of the composition selected from the group comprising of Beeswax, Coconut Oil, and Shea Butter. The moisture barrier agent of the composition selected from the group comprising of Aluminum Hydroxide Gel, Cocoa butter, glycerin, Zinc Oxide, Coconut Oil, Acid Mantle, Petroleum, Shark Liver Oil, Lanolin, Mineral Oil, White Petroleum, Starch, Cod Liver Oil, and Kaolin. The carrier agent of the composition selected from the group comprising of Soybean Oil, Canola Oil, Beeswax, Jojoba Oil, Sweet Almond Oil, Olive Oil, and Sesame Seed Oil. 
     The composition for administering topical and external topical and external body products may further include an anesthetics agent, an analgesics agent, an antimicrobial agent, a pH balancing agent, and other related agents. Examples of the aforementioned include but are not limited to the anesthetics agent of the composition selected from the group comprising of Benzocaine, Benzyl Alcohol, Dibucaine, Dyclonine, Lidocaine, Pramoxine, and Tetracaine. The analgesics agent of the composition selected from the group comprising of Menthol, Camphor, Juniper Tar, Rosemary Oil, and Chamomile. The antimicrobial agent of the composition selected from the group comprising of Coconut Oil, Jojoba Oil, Boric Acid, Hydrastis, Phenol, Benzalkonium Chloride, Cetylpyridinium Chloride, Benzethonium Chloride, and Resoricol. An example of the pH-balancing agent includes but is not limited to Lavender Oil. 
     Referring now specifically to the drawings, in which identical or similar parts are designated by the same reference numerals throughout, a detailed description of the present invention is given. It should be understood that the following detailed description relates to the best presently known embodiment of the invention. However, the present invention can assume numerous other embodiments, as will become apparent to those skilled in the art. 
     Now referring to FIGS.  1 , 2 , and  3 ,  FIG. 1  shows a top view of an embodiment of an anal/vaginal treatment composition of the present invention.  FIG. 2  shows a side view of the anal/vaginal treatment composition  10  of  FIG. 1 . Anal/vaginal treatment composition  10  generally comprises a single dose  11  of the anal/vaginal treatment composition sandwiched between a first protective layer  12  and a second protective layer  13 . Protective layers  12  and  13  may be composed of a variety of materials that are attachable and yet cleanly peelable from the treatment composition. Examples of possible materials for protective layers  12  and  13  include but are not limited to wax paper, plastic wrap, parchment paper, and aluminum foil. 
     A feature of the present invention is that treatment composition  10  is preferably maintained in solid form until treatment composition  10  comes into contact with a human body. Upon contact onto the intended area, a phase change of treatment composition  10  from a solid state to a lubricating state is triggered by temperature or pressure or a combination thereof. The lubricating state is defined as a state in which treatment composition  10  may be spreadable on the intended area of the body and ranging from a cream, salve or ointment to a free flowing liquid and anywhere in between. 
     As shown in the embodiment of  FIGS. 1 and 2 , single dose  11  is individually wrapped with a plastic wrapping container  14  or the like for single use application. Preferable, each individually wrapped piece of single dose  11  is designed and sealed to contain the single dose  11  in a way that if the single dose  11  gets warmed and melts such as due to shipping circumstances or improper storage, single dose  11  may regain its solid state and original shape because of the manner in which single dose  11  is packaged as soon as the surrounding temperature falls within a prescribed range, preferable a range that is lower than body temperature. 
     In regards to the size of single dose  11 , the size of single dose  11  may vary according to the age range, size, and body type of the receiver and the purpose single dose  11  is designated for. For example, the size of single dose  11  may be smaller for a children&#39;s&#39; diaper rash product and larger for an adults&#39; anal/vaginal irritation. Although it should be construed as limiting, an example for the sizes of single dose  11  may comprise a length ranging between 0.01 to 12 inches, a width ranging between 0.01 to 12 and a thickness ranging between 0.01 to 8 inches. It is anticipated that treatment composition  10  may be sold in a container containing a plurality of individually wrapped single dose  11  of varying sizes to treat multiple individuals of varying ages and sizes. 
       FIG. 3  shows a side view of an embodiment of an anal/vaginal treatment composition comprising a roll  15  containing multiple dosage of anal/vaginal treatment composition  16 . Multiple dosage of anal/vaginal treatment composition  16  is sandwiched between a first protective layer  17  and a second protective layer  18 . Similar to protective layers  12  and  13 , protective layers  17  and  18  may be composed of a variety of materials that are attachable and yet cleanly peelable from the treatment composition. Examples of possible materials for protective layers  17  and  18  include but are not limited to wax paper, plastic wrap, parchment paper, and aluminum foil. Roll  15  allows a user to customize a single dose of anal/vaginal treatment composition  16  for treatment on a receiver based on the measurements of the receiver&#39;s body. 
     For example, in customizing a single dose of anal/vaginal treatment composition  16  the user may first visually estimate a suitable size or amount of anal/vaginal treatment composition  16  required for a single dose on a particular receiver based trial and error, product pre-measurement instructions or the user&#39;s prior experience. Once the suitable size or amount of anal/vaginal treatment composition  16  has been determined, the user may either tear or cut the desired amount from roll  15  and use accordingly. 
     Referring back to  FIGS. 1 and 2 , in administering treatment composition  10 , the user first peels first protective layer  12  from the single dose of anal/vaginal treatment composition  11  to expose a body-treating surface while maintaining a second protective layer  13  on the single dose of anal/vaginal treatment composition  11 . The user then applies the body-treating surface of the single dose of anal/vaginal treatment composition  11  to the receiver&#39;s body while preventing the user&#39;s fingers from coming into contact with the receiver&#39;s skin. The single dose of anal/vaginal treatment composition  11  is then engaged to the receiver&#39;s body to trigger a phase change of the single dose of anal/vaginal treatment composition  11  from a solid state to a lubricating state to treat the desired region of the receiver&#39;s body. It should be noted that once in the lubricating state single dose of anal/vaginal treatment composition  11  may be self-spreading by movement of the receiver&#39;s buttock cheeks thereby reducing the work required by the user in the application of single dose of anal/vaginal treatment composition  11  to the receiver&#39;s body. 
     In regards to the second protective layer  13 , the user may use the second protective layer  13  to apply the body-treating surface of the single dose of anal/vaginal treatment composition  11  to the receiver&#39;s body to prevent the user&#39;s fingers from coming into contact with the receiver&#39;s skin or with single dose of anal/vaginal treatment composition  11 . The user may optionally peel the second protective layer  13  from the single dose of anal/vaginal treatment composition  11  and then apply the single dose of anal/vaginal treatment composition  11  to the receiver&#39;s body. Although the user&#39;s fingers will be touching single dose of anal/vaginal treatment composition  11 , this method is still sanitary since the user&#39;s fingers would only be touching the topside of single dose of anal/vaginal treatment composition  11  and will not come from into contact with the receiver&#39;s body part. 
     Since the user&#39;s fingers rarely if ever come in direct contact with the skin of the receiver&#39;s body part including the receiver&#39;s anal/vaginal area, the present invention makes the interaction and application of body product(s) more hygienic and more convenient due to the lack of a runny, sticky mess that such products are known to create. 
     In the individually pre-wrapped single dose form each application is intended and packaged for a single use. Each individually wrapped piece of single dosage of treatment composition is designed and sealed to contain the product in a way that if the body product did in fact get warm and melts, the product does not leak. The individually wrapped piece of treatment composition may also be sized and package to discreetly be carried in a female&#39;s purse and various diaper bags and carry-a-longs. 
     An example of the steps of making the composition for administering topical and external topical and external body products of the present comprising the steps of boiling 2-3 inches of water in a sauce pan and placing a metal bowl inside boiling water. The ingredient with highest melting point, in this instance Beeswax, is then added into the metal bowl. After the beeswax has melted Coconut oil is then added into the metal bowl and stirred until the beeswax and oils are combined. 
     Once the beeswax and coconut oil are in a liquid state, Sweet Almond Oil, Jojoba Oil, Lavender Oil, Calendula Oil, Vitamin E, Zinc Oxide are then added to the metal bowl. The ingredients are then stirred in the metal until all of the ingredients are blended. 
     Once blended, the composition is then transferred onto flat wax paper or the like and formed into a plurality of single dosages that are roughly 1.5″ wide and 2″ long. The single dosages of composition are then allowed to harden such as by placing them in a hardening in a freezer for 5-10 minutes. 
     After the single dosages of composition have harden and cooled the wax paper is then peeled away and the single dosages of composition may be stored in a hard-shelled container with wax paper in between each piece at room temperature. 
     The present invention also includes a sanitary and no-mess method of administering topical and external topical and external body products for the prevention and treatment of anal/vaginal ailments for people in all age ranges. A feature of the present invention is that by using the aforementioned method of delivery, the user&#39;s fingers rarely if ever come in direct contact with the skin of the receiver&#39;s anal/vaginal area, making the interaction and application of body product hygienic and very convenient due to the lack of a runny, sticky mess that viscous products create. The method generally comprises the steps of (1) selecting a single dose of anal/vaginal treatment composition  11  sandwiched between a pair of protective layers  12 ,  13 ; (2) peeling a first protective layer  12  from the single dose of anal/vaginal treatment composition  11  to expose a body-treating surface while maintaining a second protective layer  13  on the single dose of anal/vaginal treatment composition  11 ; (3) applying the body-treating surface of the single dose of anal/vaginal treatment composition  11  to the receiver&#39;s body while preventing the user&#39;s fingers from coming into contact with the receiver&#39;s skin; and (4) maintaining the single dose of anal/vaginal treatment composition  11  to the receiver&#39;s body to trigger a phase change of the single dose of anal/vaginal treatment composition  11  from a solid state to a lubricating state. 
     The above method may further include the steps of (6) selecting a single dose of anal/vaginal treatment composition  11  comprising a melting agent, a healing agent, a hardening agent, a moisture barrier agent, and a carrier agent in the solid state; (7) peeling the second protective layer  13  from the single dose of anal/vaginal treatment composition  11  and then applying the body-treating surface of the single dose of anal/vaginal treatment composition  11  to the receiver&#39;s body while preventing the user&#39;s fingers from coming into contact with the receiver&#39;s skin; (8) using the second protective layer  13  to apply the body-treating surface of the single dose of anal/vaginal treatment composition  11  to the receiver&#39;s body while preventing the user&#39;s fingers from coming into contact with the receiver&#39;s skin; (9) obtaining an individually pre-wrapped dose of anal/vaginal treatment composition  11 ; and (10) customizing a single dose of anal/vaginal treatment composition from a roll of anal/vaginal treatment composition based on the measurements of the receiver&#39;s body.